Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Spondyloarthritis family · A closer look at PsA

PsA in later life: several conditions, one workable plan

When psoriatic arthritis shares the picture with other conditions, the aim is to control inflammation while keeping treatment practical and preserving what matters in daily life.

Olga Goodman, MD · Sources checked 27 September 2026

Chapter 15 of 21

The essentials

Age alone does not describe a person's health or treatment needs. Review organ function, medicines, infection history, mobility and support together. Agree goals and a named coordinator rather than collecting disconnected plans.

Start with the person and the goals

Tell the team what you most want to keep doing: dressing without help, walking to a shop, sleeping comfortably or caring for someone. Include treatment burden—appointments, travel, monitoring and the work of taking medicines. Multimorbidity care should reflect personal priorities. 5

Persistent inflammation still deserves assessment in later life. Do not explain every new swollen joint or loss of function as ageing. Conversely, not every painful movement means active PsA: osteoarthritis, old damage and muscle weakness may also contribute. 10

Look beyond the number of birthdays

Kidney and liver function, cardiovascular disease, past infections and other conditions affect treatment choices. Frailty describes reduced resilience to illness or other stress; it is not interchangeable with age. If falls, weight loss, slower walking or difficulty with daily tasks are emerging, bring them to the review. 5, 10

Ask what can improve as inflammation settles and what may need rehabilitation or other help. A plan should account for vision, hearing, memory, hand function and the ability to open packaging or use an injection device.

Review the complete medicine list

Include prescriptions from every clinician, non-prescription pain and sleep medicines, vitamins and herbal products. Bring the actual packages if names or schedules are unclear. A pharmacist can help identify duplicated ingredients and interactions. 6

For each medicine ask: what is its purpose now, what benefit should we notice, what monitoring is needed and who renews it? If a medicine is no longer useful, agree how to reduce or stop it safely. Do not use a general deprescribing list to stop disease-modifying treatment yourself. 5, 6

Prevention belongs in the treatment plan

Review vaccinations, infection history and the practical route for reporting illness. Influenza, pneumococcal and recombinant shingles vaccines are relevant topics for many people receiving immunosuppressive therapy; eligibility and timing follow the current local schedule and the actual medicine. Live vaccines require a separate discussion. 9

Discuss cardiovascular and clotting history and smoking when a JAK inhibitor is considered. The FDA safety warning is particularly relevant to individual risk assessment; a tablet is not inherently safer than an injection. Trial findings in higher-risk rheumatoid arthritis cannot be converted into a personal PsA risk percentage. 12

Preserve function without making care exhausting

Ask for a movement and rehabilitation plan that considers balance, strength, fatigue and painful joints. Also review unintentional weight loss, difficulty obtaining food and help needed at home. Choose one or two workable changes with a review date.

A useful functional goal is observable: for example, managing breakfast with less hand pain. Record what improved, what stayed difficult and whether dizziness, sleepiness or another symptom appeared after a treatment change. Bring this account to the team.

Coordinate the next steps

Request one current plan that names who will review results and resolve conflicting instructions. Family or carers can join if you want them involved; your priorities should remain visible.

Coordinate the next steps
Part of the planMake it specific
Disease and functionThe inflammation target and one daily activity to improve; when each will be reviewed.
Medicines and testsCurrent schedule; monitoring dates; responsible prescriber; whom to ask about a new over-the-counter medicine.
Support and illnessHelp with devices, appointments or transport; contact for a new infection or sudden decline.

Go deeper

Why several good guidelines may still need one joint decision

A single-disease guideline cannot automatically settle every priority for someone with several conditions. The combined burden of medicines and appointments may be greater than any one specialist sees. NICE's multimorbidity guidance addresses this problem explicitly. 5

Ask the team to explain the likely benefit over a meaningful time frame, the harms relevant to you and the alternatives. A realistic goal can combine inflammation control with maintaining independence. Realistic does not mean accepting avoidable pain without assessment.

Questions for your visit

  1. Which symptoms suggest active PsA, and which need another explanation?
  2. How do my kidney, liver, heart and infection history change the choice?
  3. Can a clinician or pharmacist review all my medicines together?
  4. Who coordinates the plan, and which daily activity will we use to judge benefit?

When to seek urgent help

A painful red eye, light sensitivity or a sudden change in vision needs urgent assessment. A newly hot, swollen joint, especially with fever or feeling unwell, also needs prompt assessment.

Sources & evidence notes

Sources checked 27 September 2026

The dates identify the versions used. General guidance needs an individual decision; drug labels, age-specific indications and local vaccination schedules also matter.

  1. NICE. Multimorbidity: clinical assessment and management. NG56. 2016.
  2. National Institute on Aging. Taking medicines safely as you age.
  3. Bass AR et al. ACR guideline for vaccinations in rheumatic and musculoskeletal diseases. 2022 guideline. Arthritis Rheumatol. 2023.
  4. Coates LC et al. GRAPPA treatment recommendations 2021. Nat Rev Rheumatol. 2022.
  5. FDA. Warnings for JAK inhibitors: serious cardiovascular events, cancer, thrombosis and death. September 2021.

Educational information for patients and caregivers. This personal publication is not the clinic portal and does not provide individual diagnosis or treatment. Discuss medication changes with your own care team.

© 2026 Olga Goodman, MD · A RheumaView publication. Copying without attribution prohibited.

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Care coordinationPsoriasisPsoriatic arthritisQuality of lifeSpondyloarthritis